News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,224 Results
Type
Article (39899)
Company Profile (250)
Press Release (657075)
Section
Business (204962)
Career Advice (2016)
Deals (35509)
Drug Delivery (96)
Drug Development (81248)
Employer Resources (169)
FDA (16249)
Job Trends (14884)
News (346662)
Policy (33060)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2561)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49575)
ALS (77)
Alzheimer's disease (1328)
Antibody-drug conjugate (ADC) (98)
Approvals (16234)
Artificial intelligence (209)
Autoimmune disease (10)
Automation (14)
Bankruptcy (357)
Best Places to Work (11666)
BIOSECURE Act (18)
Biosimilars (94)
Biotechnology (177)
Bladder cancer (50)
Brain cancer (23)
Breast cancer (232)
Cancer (1791)
Cardiovascular disease (133)
Career advice (1680)
Career pathing (28)
CAR-T (130)
Cell therapy (373)
Cervical cancer (14)
Clinical research (65585)
Collaboration (696)
Compensation (391)
Complete response letters (19)
COVID-19 (2588)
CRISPR (31)
C-suite (177)
Cystic fibrosis (97)
Data (1712)
Decentralized trials (2)
Denatured (14)
Depression (35)
Diabetes (225)
Diagnostics (6318)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (104)
Drug pricing (99)
Drug shortages (24)
Duchenne muscular dystrophy (64)
Earnings (86067)
Editorial (27)
Employer branding (21)
Employer resources (145)
Events (111744)
Executive appointments (586)
FDA (17209)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (629)
Gene editing (84)
Generative AI (18)
Gene therapy (257)
GLP-1 (664)
Government (4637)
Grass and pollen (4)
Guidances (45)
Healthcare (18939)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (89)
Indications (23)
Infectious disease (2707)
Inflammatory bowel disease (125)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (69)
Interviews (313)
IPO (16510)
IRA (40)
Job creations (3652)
Job search strategy (1431)
Kidney cancer (9)
Labor market (26)
Layoffs (443)
Leadership (14)
Legal (7956)
Liver cancer (69)
Lung cancer (260)
Lymphoma (120)
Machine learning (2)
Management (57)
Manufacturing (243)
MASH (57)
Medical device (13345)
Medtech (13350)
Mergers & acquisitions (19398)
Metabolic disorders (585)
Multiple sclerosis (58)
NASH (16)
Neurodegenerative disease (69)
Neuropsychiatric disorders (23)
Neuroscience (1756)
NextGen: Class of 2025 (6534)
Non-profit (4520)
Northern California (2207)
Now hiring (35)
Obesity (323)
Opinion (197)
Ovarian cancer (61)
Pain (68)
Pancreatic cancer (68)
Parkinson's disease (118)
Partnered (17)
Patents (177)
Patient recruitment (80)
Peanut (46)
People (57136)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20398)
Phase II (28875)
Phase III (21541)
Pipeline (800)
Podcasts (39)
Policy (100)
Postmarket research (2575)
Preclinical (8614)
Press Release (65)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (334)
Real estate (5927)
Recruiting (64)
Regulatory (22248)
Reports (43)
Research institute (2330)
Resumes & cover letters (349)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (58)
Series A (113)
Series B (68)
Service/supplier (12)
Sickle cell disease (49)
Southern California (1886)
Special edition (13)
Sponsored (28)
Startups (3584)
State (2)
Stomach cancer (11)
Supply chain (55)
The Weekly (24)
United States (19350)
Vaccines (628)
Venture capitalists (34)
Webinars (12)
Weight loss (222)
Women's health (30)
Worklife (13)
Date
Today (186)
Last 7 days (813)
Last 30 days (2915)
Last 365 days (34474)
2025 (5588)
2024 (35303)
2023 (40166)
2022 (51322)
2021 (55912)
2020 (54357)
2019 (46927)
2018 (35314)
2017 (32257)
2016 (31697)
2015 (37746)
2014 (31479)
2013 (26493)
2012 (28708)
2011 (29395)
2010 (27472)
Location
Africa (732)
Alabama (48)
Alaska (7)
Arizona (213)
Arkansas (12)
Asia (37751)
Australia (6193)
California (5016)
Canada (1775)
China (413)
Colorado (229)
Connecticut (240)
Delaware (110)
Europe (81077)
Florida (740)
Georgia (172)
Idaho (58)
Illinois (464)
India (20)
Indiana (273)
Iowa (7)
Japan (127)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (768)
Massachusetts (3817)
Michigan (201)
Minnesota (346)
Mississippi (2)
Missouri (73)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1416)
New Mexico (27)
New York (1431)
North Carolina (864)
North Dakota (7)
Northern California (2207)
Ohio (177)
Oklahoma (13)
Oregon (32)
Pennsylvania (1143)
Puerto Rico (6)
Rhode Island (23)
South America (1104)
South Carolina (13)
South Dakota (1)
Southern California (1886)
Tennessee (84)
Texas (733)
Utah (155)
Virginia (116)
Washington D.C. (54)
Washington State (479)
West Virginia (3)
Wisconsin (44)
697,224 Results for "sinoveda canada inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada
February 26, 2025
·
4 min read
Press Releases
Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)
February 20, 2025
·
4 min read
Sinoveda’s Long Covid Product Attracts International Attention
Sinoveda is a health brand that is bringing innovative, herbally-based precision to drug discovery.
June 28, 2023
·
3 min read
BioMidwest
Health Brand Sinoveda’s Rapid Rise in the U.S. Is Soaking Up the Limelight
Sinoveda is an innovative Canadian-based health brand that is bringing Eastern and Western Medicine together.
June 28, 2023
·
3 min read
Press Releases
Boehringer Canada Announces Availability of SPEVIGO® for expanded indication in Canada
February 6, 2025
·
7 min read
Policy
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
C3i Center Inc (C3i) announced it has received regulatory approval, in the form of a Drug Establishment License (DEL), to commercially produce cell therapies, making C3i the first CDMO in Canada to achieve this milestone.
June 20, 2024
·
2 min read
Press Releases
Pharmascience Canada strengthens its commitment to patients with an antihistamine treatment
February 9, 2025
·
2 min read
Press Releases
Fresenius Kabi Canada has received a Health Canada Notice of Compliance (NOC) for Otulfi™* an Ustekinumab Biosimilar
January 9, 2025
·
7 min read
Press Releases
Kashiv BioSciences, LLC Obtains Marketing Authorization for Pegfilgrastim Injection from Health Canada
February 26, 2025
·
2 min read
BioSyent In-Licenses Endocrinology Product for Canada
BioSyent Inc. is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc., has entered into an agreement with a European partner for an exclusive license to register, market, sell and distribute a new endocrinology product in Canada.
June 12, 2024
·
2 min read
1 of 69,723
Next
